Titre:
  • Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment
Auteur:Vincent, Jean Louis; Bernard, Gordon; Beale, Richard; Doig, Christopher; Putensen, Christian; Dhainaut, Jean-Francois; Artigas, Antonio; Fumagalli, Roberto; Macias, William; Wright, Theressa; Wong, Kar; Sundin, David; Turlo, Mary Ann; Janes, Jonathan
Informations sur la publication:Critical care medicine, 33, 10, page (2266-2277)
Statut de publication:Publié, 2005-10
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Activated protein C
Clinical trial
Drotrecogin alfa (activated)
Early treatment
ENHANCE
Severe sepsis
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0090-3493
info:doi/10.1097/01.CCM.0000181729.46010.83
info:scp/26444604781